The Asia-Pacific market for hemodynamic monitoring is expected to reach USD XX million by the end of 2021, growing at a CAGR of around XX% from 2016 to 2021.
Critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor the cardiac activity. The hemodynamic systems give information about blood pressure, blood volume and fluid balance. The prevalence of heart disorders is on the rise and this has created a demand for hemodynamic monitoring systems. Most of the geriatric population suffers from hypertension & diabetes and requires round the clock monitoring. This has generated the need for home- based monitoring systems. The market is growing continuously due to the technological shift from invasive monitoring systems to minimally and non-invasive monitoring systems.
The Asia-Pacific hemodynamic monitoring market is segmented on the basis of type of systems (minimally invasive monitoring systems, invasive monitoring systems and non-invasive monitoring systems), application (laboratory-based monitoring systems, home-based monitoring systems and hospital-based monitoring systems), type of product (pressure monitors, catheters, connecting tubes, guidewires, IV fluid, and transducers) and region (China, Japan, India, Australia, South Korea, Israel and Others).
Some of the key players in the market are:
What the Report Offers
Market definition along with identification of key drivers and restraints for the market.
Market analysis for the Asia-Pacific hemodynamic monitoring market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the Asia-Pacific hemodynamic monitoring market on both a global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.3 Market Restraints
4. Porter’s Five Force Analysis
4.1 Bargaining Power of Suppliers
4.2 Bargaining Power of Buyers
4.3 Degree of Competition
4.4 Threat of Substitution
4.5 Threat of New Entrants
5. Market Segmentation
5.1 Asia-Pacific Hemodynamic Monitoring Market
5.1.1 By Type of Systems
184.108.40.206 Minimally Invasive Monitoring Systems
220.127.116.11 Invasive Monitoring Systems
18.104.22.168 Non-Invasive Monitoring Systems
5.1.2 By Application
22.214.171.124 Laboratory-Based Monitoring Systems
126.96.36.199 Home-Based Monitoring Systems
188.8.131.52 Hospital-Based Monitoring Systems
5.1.3 By Type of Product
184.108.40.206 Pressure Monitors
220.127.116.11 Connecting Tubes
18.104.22.168 IV Fluid
5.1.4 By Geography
22.214.171.124.5 South Korea
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to New Market Players
7. Company Profiles
7.2 Cheetah Medical
7.3 ICU Medical
7.4 Tensys Medical
7.5 Schwarzer Cardiotek
7.6 Evena Medical
7.7 Edwards Lifesciences
7.8 CN Systems